ArticleProceedings of the National Academy of Sciences of the United States of America2026

Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Laura Antonucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.